Implementing REmote SymPtom mOnitoring and maNagement (RESPONd): Evaluating the Impact on Cancer Patients, System Efficiency, and Economic Outcomes
Sponsor: University of Calgary
Trial Details
| Condition | Cancer |
| Intervention | Remote Symptom Monitoring and Management; Clinic Team Huddle |
| Phase | NA |
| Status | Recruiting |
| Participants | 1,055 |
| Est. Completion | 30 Nov 2026 |
| Last Updated | 30 Apr 2026 |
Primary Outcome
Quality of Life (QoL); Self-rated health; Rate of Emergency department (ED) visits; Rate of Hospital admissions; Economic outcome measure - Incremental cost-effectiveness ratio (ICER); Economic outcome measures - Quality adjusted life years (QUALYs)
Eligibility Criteria
Inclusion Criteria
Inclusion Criteria: * Age ≥ 18 * Have cancer * Receiving care in one of the participating clinics. * Able to sign up for MyAHS Connect and consent. * Have access to a digital device at home * Able to complete their electronic PROs questionnaire without support from the clinic team on a weekly (patients on active treatment) or monthly (patients on follow-up) basis, for the duration of the intervention or until they are discharged from the clinic. * Regular access to a telephone in order for the study nurse to call patients to provide symptom management support. Exclusion Criteria: * Patients with cognitive disabilities or who cannot reliably report symptoms independently. * Patients not residing in Alberta, as government-issued ID is required to register for MyAHS Connect. * Patients who do not have regular access to a telephone, as the study nurse needs to be able to call patients to provide symptom management support. * Patients who do not speak English, or who do not have an English-speaking friend, family member, or caregiver to assist them, as the electronic PROs questionnaire is only available in English at this time.
Trial Sites
Countries
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service